# Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance

> **NCT00060866** · PHASE4 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 24 (—)

## Conditions studied

- Neurocardiogenic Syncope

## Interventions

- **DRUG:** Propranolol

## Key facts

- **NCT ID:** NCT00060866
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 24 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00060866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00060866, "Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00060866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*